Affymetrix Inc. (AFFX): New Analyst Report from Zacks Equity Research - Zacks ...

02-12-2013 NASDAQComments (0)

AffymetrixPharmaceutical

Affymetrix rebounded by reporting earnings for the second time since the first quarter of 2011. Adjusted earnings of $0.05 for the 2013-third quarter beat the Zacks Consensus Estimate by $0.03. Revenues of $80.4 million also exceeded the mark.

Read more on NASDAQ

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top